Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies 

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study  Manjula Kurella Tamura,
Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency.
Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.
Uric Acid and Long-term Outcomes in CKD
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD  Lesley A. Inker, MD, Brad C. Astor, PhD, Chester.
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Diagnosis and Management of Chronic Kidney Disease
A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients.
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study  Manjula Kurella Tamura,
Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey  Orlando M. Gutiérrez, MD, MMSc, Tamara.
Metabolic Complications in Elderly Adults With CKD
Volume 91, Issue 3, Pages (March 2017)
Development of Reduced Kidney Function in Rheumatoid Arthritis
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Francesca Mallamaci, MD, Giovanni Tripepi, PhD 
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
A Decade After the KDOQI CKD Guidelines
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.
Comparison of the Performance of 2 GFR Estimating Equations Using Creatinine and Cystatin C to Predict Adverse Outcomes in Elderly Individuals  Insa E.
Cardiovascular Disease and CKD: Core Curriculum 2010
Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study  Digsu.
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Andrew Narva  American Journal of Kidney Diseases 
Evaluation of the Potential Living Kidney Donor
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Guidelines for the Older Adult With CKD
Comparison of Drug Dosing Recommendations Based on Measured GFR and Kidney Function Estimating Equations  Lesley A. Stevens, MD, MS, Thomas D. Nolin,
Lifetime Incidence of CKD Stages 3-5 in the United States
Volume 91, Issue 1, Pages (January 2017)
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial  Keith Norris, MD, Jacque Bourgoigne, MD, Jennifer.
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS 
Socioeconomic Status and Reduced Kidney Function in the Whitehall II Study: Role of Obesity and Metabolic Syndrome  Talal M. Al-Qaoud, MD, MSc, Dorothea.
Julie A. Wright Nunes, MD, MPH, Kerri L
Polyunsaturated Fatty Acids and Kidney Disease
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L
Nephrology: As It Was Then, But Is Not Now
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Elaine Ku, Joel D. Kopple, Kirsten L. Johansen, Charles E
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings.
Study Designs in Patient-Oriented Research
Evidence and Outcomes in CKD
Within-Person Variability in Kidney Measures
Drug Dose Adjustments in Patients With Renal Impairment
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary  Adam T. Whaley-Connell, DO, MSPH, Joseph.
The Use of Vaccines in Adult Patients With Renal Disease
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Patient Safety Issues in CKD: Core Curriculum 2015
Supportive care for patients with renal disease: Time for action
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Dialysis Research and N-of-1 Trials: Made for Each Other?
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP)  Adam Whaley-Connell, DO, MSPH 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies  James P. Lash, MD, Ana C. Ricardo, MD, MPH, Jason Roy, PhD, Rajat Deo, MD, Michael Fischer, MD, MSPH, John Flack, MD, MPH, Jiang He, MD, PhD, Martin Keane, MD, Claudia Lora, MD, MS, Akinlolu Ojo, MD, PhD, Mahboob Rahman, MD, Susan Steigerwalt, MD, Kaixiang Tao, PhD, Myles Wolf, MD, MMSc, Jackson T. Wright, MD, PhD, Alan S. Go, MD Lawrence J. Appel, MD, MPH, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, Jiang He, MD, PhD, John W. Kusek, PhD, James P. Lash, MD, Akinlolu Ojo, MD, PhD, Mahboob Rahman, MD, Raymond R. Townsend, MD James P. Lash, MD, Ana C. Ricardo, MD, MPH, Jason Roy, PhD, Rajat Deo, MD, Michael Fischer, MD, MSPH, John Flack, MD, MPH, Jiang He, MD, PhD, Martin Keane, MD, Claudia Lora, MD, MS, Akinlolu Ojo, MD, PhD, Mahboob Rahman, MD, Susan Steigerwalt, MD, Kaixiang Tao, PhD, Myles Wolf, MD, MMSc, Jackson T. Wright, MD, PhD, Alan S. Go, MD Lawrence J. Appel, MD, MPH, Harold I. Feldman, MD, MSCE, Alan S. Go, MD, Jiang He, MD, PhD, John W. Kusek, PhD, James P. Lash, MD, Akinlolu Ojo, MD, PhD, Mahboob Rahman, MD, Raymond R. Townsend, MD  American Journal of Kidney Diseases  Volume 68, Issue 4, Pages 545-553 (October 2016) DOI: 10.1053/j.ajkd.2016.03.429 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Analytic cohort flowchart. Abbreviations: ABI, ankle-brachial index; CRIC, Chronic Renal Insufficiency Cohort; FGF-23, fibroblast growth factor 23. American Journal of Kidney Diseases 2016 68, 545-553DOI: (10.1053/j.ajkd.2016.03.429) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Event rates by race/ethnicity adjusted for age, sex, baseline estimated glomerular filtration rate, diabetes, and clinical site. American Journal of Kidney Diseases 2016 68, 545-553DOI: (10.1053/j.ajkd.2016.03.429) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions